EB-1C Remanded — Pharmaceuticals (2020): the AAO found that the Director did not correctly apply the

Decision Summary

The appeal was remanded because the AAO found that the Director did not correctly apply the law, provide an accurate analysis of the issues, or offer adequate support for the finding of fraud. Although the Director's decision was withdrawn, the AAO identified remaining inconsistencies regarding the qualifying relationship, the beneficiary's foreign employment, and the petitioner's ability to pay, requiring the case to be sent back for further consideration.

Criteria Discussed

Sign up free to download the original PDF